AI Business LensTHE BUSINESS OF AI, FOR PEOPLE WHO TEACH IT OR LEARN FROM IT
TechRadar · November 3, 2026 · On the brief until November 17, 2026

Palantir cofounder wants a 30,000 monkey farm in the US — because AI jacked up macaque prices by 700% in seven years

BiologyBiomedical EngineeringSupply Chain & Logistics
THE AI ANGLE
Accelerating drug discovery to create more candidates for animal testing

A startup backed by Palantir cofounder Joe Lonsdale plans to build a US facility to breed 30,000 research macaques over two decades. Rapid drug candidate generation from AI and foreign export bans have driven monkey prices above $20,000. The project aims to secure domestic supplies for preclinical testing, though it faces long breeding cycles and intense animal welfare opposition.

Summary written by AI Business Lens with an AI model from the article at techradar.com. It is not the article, and the publisher has not reviewed it. For publishers.

THE TEACHING ANGLE
Rapid digital drug discovery creates an acute physical bottleneck when preclinical testing depends on slow biological breeding cycles and contentious animal use.

Read the original at techradar.com   Generate teaching or study materials

Instructors get discussion guides, assignments, and mini-cases. Students and readers get a plain summary, points to raise, an exercise, and a self-check. All built from the full article. A free account saves stories and gives you three generations. Stories stay on the brief for 14 days. After that this page keeps the link to the original.

More in Biology